{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-008280","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.867131+00:00","generated_at":"2026-05-16T11:04:28.420693+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Prelude Therapeutics furnishes investor presentation; no material new information disclosed","bullets":["Filed an investor presentation dated January 2026 for use in investor meetings starting Jan 9.","The presentation includes forward-looking statements and general corporate overview.","No specific new clinical data, financial results, or corporate milestones were released.","The filing is a routine Regulation FD disclosure; presentation content not provided in full detail."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-008280","json":"https://secwatch.observer/filing/0001193125-26-008280.json","markdown":"https://secwatch.observer/filing/0001193125-26-008280.md","text":"https://secwatch.observer/filing/0001193125-26-008280.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/0001193125-26-008280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/prld-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:04:28.420693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}